Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason A Roberts

Showing results (131-140 of 682) with videos related to

Pageof 69
Sort By:
Antimicrobial Agents and Chemotherapy|March 16, 2026
Reply to Lai and Huang, "Which beta-lactam infusion strategy is superior in ICU pneumonia? A Bayesian network meta-analysis of continuous, extended, and intermittent approaches"Yixuan Li, Jason A Roberts, Mohd H Abdul-Aziz, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|May 13, 2014
Simultaneous determination of seven β-lactam antibiotics in human plasma for therapeutic drug monitoring and pharmacokinetic studiesFekade Bruck Sime, Michael S Roberts, Jason A Roberts, et al.
Communicable Diseases Intelligence Quarterly Report|November 25, 2010
Annual report of the Australian National Poliovirus Reference Laboratory, 2009Jason A Roberts, Linda Hobday, Sophie Polychronopoulos, et al.
International Journal of Antimicrobial Agents|December 24, 2013
Cefazolin plasma protein binding in different human populations: more than cefazolin-albumin interactionAnne Smits, Jason A Roberts, Jane W A Vella-Brincat, et al.
Journal of Medical Microbiology|July 26, 2017
Evolutionary changes in the capsid P2 region of Australian strains of the norovirus GII.Pe_GII.4Leesa D Bruggink, Jean M Moselen, Jason A Roberts, et al.
The Journal of Antimicrobial Chemotherapy|July 19, 2015
Therapeutic drug monitoring of the β-lactam antibiotics: what is the evidence and which patients should we be using it for?Angela Huttner, Stephan Harbarth, William W Hope, et al.
Infectious Diseases and Therapy|September 13, 2015
Antimicrobial Stewardship in Australian Hospitals and Other SettingsKelly A Cairns, Jason A Roberts, Menino O Cotta, et al.
Anaesthesia, Critical Care & Pain Medicine|November 3, 2021
A personalised approach to antibiotic pharmacokinetics and pharmacodynamics in critically ill patientsAaron J Heffernan, Sazlyna Mohd Sazlly Lim, Jeffrey Lipman, et al.
Current Opinion in Infectious Diseases|October 10, 2018
How to optimize antibiotic pharmacokinetic/pharmacodynamics for Gram-negative infections in critically ill patientsAaron J Heffernan, Fekade B Sime, Fabio S Taccone, et al.
Current Opinion in Critical Care|July 24, 2012
Improving antibiotic dosing in special situations in the ICU: burns, renal replacement therapy and extracorporeal membrane oxygenationJanattul-Ain Jamal, Caleb J P Economou, Jeffrey Lipman, et al.
Pageof 69

Showing results (131-140 of 682) with videos related to

Sort By:
Pageof 69
Antimicrobial Agents and Chemotherapy|March 16, 2026
Reply to Lai and Huang, "Which beta-lactam infusion strategy is superior in ICU pneumonia? A Bayesian network meta-analysis of continuous, extended, and intermittent approaches"Yixuan Li, Jason A Roberts, Mohd H Abdul-Aziz, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|May 13, 2014
Simultaneous determination of seven β-lactam antibiotics in human plasma for therapeutic drug monitoring and pharmacokinetic studiesFekade Bruck Sime, Michael S Roberts, Jason A Roberts, et al.
Communicable Diseases Intelligence Quarterly Report|November 25, 2010
Annual report of the Australian National Poliovirus Reference Laboratory, 2009Jason A Roberts, Linda Hobday, Sophie Polychronopoulos, et al.
International Journal of Antimicrobial Agents|December 24, 2013
Cefazolin plasma protein binding in different human populations: more than cefazolin-albumin interactionAnne Smits, Jason A Roberts, Jane W A Vella-Brincat, et al.
Journal of Medical Microbiology|July 26, 2017
Evolutionary changes in the capsid P2 region of Australian strains of the norovirus GII.Pe_GII.4Leesa D Bruggink, Jean M Moselen, Jason A Roberts, et al.
The Journal of Antimicrobial Chemotherapy|July 19, 2015
Therapeutic drug monitoring of the β-lactam antibiotics: what is the evidence and which patients should we be using it for?Angela Huttner, Stephan Harbarth, William W Hope, et al.
Infectious Diseases and Therapy|September 13, 2015
Antimicrobial Stewardship in Australian Hospitals and Other SettingsKelly A Cairns, Jason A Roberts, Menino O Cotta, et al.
Anaesthesia, Critical Care & Pain Medicine|November 3, 2021
A personalised approach to antibiotic pharmacokinetics and pharmacodynamics in critically ill patientsAaron J Heffernan, Sazlyna Mohd Sazlly Lim, Jeffrey Lipman, et al.
Current Opinion in Infectious Diseases|October 10, 2018
How to optimize antibiotic pharmacokinetic/pharmacodynamics for Gram-negative infections in critically ill patientsAaron J Heffernan, Fekade B Sime, Fabio S Taccone, et al.
Current Opinion in Critical Care|July 24, 2012
Improving antibiotic dosing in special situations in the ICU: burns, renal replacement therapy and extracorporeal membrane oxygenationJanattul-Ain Jamal, Caleb J P Economou, Jeffrey Lipman, et al.
Pageof 69